Chemicals & Materials Now!
From basic to specialty, and everything in between
Chemicals M&A wave to persist despite Q2 blip
Posted on August 18th, 2017 by Al Greenwood in Chemicals Industry News and Analysis
Chemical deal-making fell during the second quarter of 2017, but the slowdown merely marks a blip in the wave of mergers and acquisitions (M&A) that are reshaping the industry.
The consultancy PwC publishes a quarterly report on chemicals M&A. Second-quarter deals fell both in terms of the number of deals announced and their value.
Companies announced 30 deals in the second quarter worth a total of $20bn, down from 42 deals announced in Q2 2016 worth $71bn.
The decline partly reflects some big-dollar deals that were announced last year which include Bayer’s bid to acquire Monsanto.
Others are Evonik’s $3.8bn bid to buy Air Products’ Specialty & Coatings business and BASF’s $3.2bn deal to buy Chemetall from Albemarle.
Quarter on quarter, the number of deals actually rose 15% from 26 in the first quarter, PwC said. The value rose 33% from $15bn in the first quarter.
The average size of a deal was $679m, down from $1.68bn in from the same time last year and up from $582m in the first quarter.
Looking at the first half of the year, the presidential elections may have caused companies to hold back on deal-making to see how the new administration would play out, said Craig Kocak, US chemicals deals leader for PwC. Kocak did not discuss individual companies, per PwC policy.
“You cannot look at the second quarter as a standalone,” said Vijay Sarathy, US chemicals strategy partner for PwC. “You want to look at it over the last few quarters.”
In fact, the chemical industry is still in a consolidation phase that should continue in the upcoming years, PwC said in its report.
The following chart from PwC shows the number and value of deals announced during the past several quarters.
This longer perspective shows the upsurge in chemical M&A.
Companies are making deals in part to find a way to grow when the outlook is so sluggish, Sarathy said.
“The industry isn’t growing anything remotely like how it was growing way back when,” he said. “It is mature. When you are in this kind of mature phase, people are looking to grow somehow, and they are targeting M&A.”
Deal-making, however, is a one-time remedy for slow growth, Sarathy said. Once companies cut costs and achieve synergies, they will return to the slow growth levels that preceded their acquisitions.
More important, Sarathy said companies will review their portfolios after completing their deals, divesting businesses that no longer fit.
He calls this process the big sort, and it should result in companies with more logical and coherent portfolios.
Once chemical industry players complete this big sort, they should be in better touch with their customers and with the capabilities of their businesses, Sarathy said. By then, they should be in a better position to innovate and expand, thus breaking out of the slow-growth trap.
Regarding second-quarter deals, the largest announced transaction was the $10.4bn merger of equals between US-based Huntsman and Switzerland-based Clariant.
It was among the three mega deals announced during the quarter, each of which was worth at least $1bn.
The other mega deal includes NOVA Chemicals’ acquisition of Williams’s majority stake in its Geismar cracker for $2.1bn, according to PwC.
British Petroleum (BP) agreed to sell its 50% stake in the Shanghai SECCO Petrochemical Company (SECCO) to Gaoqiao Petrochemical, a subsidiary of China’s energy major Sinopec for $1.68bn.
Among the major chemical sectors, specialty chemicals were the most active, accounting for 48% of transaction and 78% of deal value in the second quarter.
Financial investors accounted for just 27% of total deal volume in the second quarter, PwC said in the report.
Private equity firms have held back from making deals, in part, because of the high valuations of the targets, Kocak said. Strategic buyers can justify these higher prices through the synergies they can achieve.
In addition, many strategic buyers can use stock to help finance acquisitions, he said.
Some private equity firms could be waiting for companies to divest businesses following their mergers, Kocak said. They may re-enter the market to acquire those businesses once they become available.
By region, Asia and Oceania were the most active, accounting for 43% of deal volume. Meanwhile, Europe accounted for 56% of deal value.
Looking ahead, PwC expects the recent wave of M&A will lead to more deals, as newly combined companies will shed businesses either to comply with the rulings from anti-trust regulators or for financing purposes. Also, money is still cheap and plentiful.
Additional reporting by Niall Swan
To find out how to read more news and analysis stories from ICIS, go to www.icis.com/about/news/
Access the white paper Making the Switch to Green Chemicals in Manufacturing: Challenges and Opportunities.
All opinions shared in this post are the author’s own.
R&D Solutions for Chemicals & MaterialsWe're happy to discuss your needs and show you how Elsevier's Solution can help.
Deputy Editor, ICIS News
Connect on LinkedIn
- Huntsman Looks to Innovation, Integration and Global Growth
- China Anti-Pollution Drive Takes Heavy Toll
- LyondellBasell / Braskem Makes Strategic Sense but Complexities Unique
- Economic Nationalism Could Disrupt Chem R&D Spending
- Back to Basics for R&D